Clinical Trials in Arizona

Showing 14201-14220 of 16,770 trials

A Bioequivalence Study of the Fixed Dose Combination Tablets of Canagliflozin and Metformin Extended Release (XR) With Respect to the Individual Components

NCT02073227

The purpose of this study is to assess the bioequivalence of the fixed dose combination (two components combined in one tablet) of canagliflozin and metformin extended release (XR) tablet (dose of 2 X 150 mg/1,000 mg) with respect to the individual components of canagliflozin (1 x 300 mg) and metformin XR tablet (4 x 500 mg) in healthy fed participants.

Healthy Volunteers

Janssen Research & Development, LLC52 participantsStarted Feb 2014

Tempe, Arizona, United States

COMPLETEDPhase 135 miles

A Bioequivalence Study of the Fixed Dose Combination Tablets of Canagliflozin and Metformin Extended Release (XR) With Respect to the Individual Components in Healthy Fed Participants

NCT02077803

The purpose of this study is to assess the bioequivalence (similarity of the drug amount in blood among the formulations) of the fixed dose combination (two components combined in one tablet) of canagliflozin and metformin extended release (XR) tablet (dose of 2 X 50 mg/1000 mg) with respect to the individual components of canagliflozin (1 x 100 mg) and metformin XR tablet (4 x 500 mg) in healthy fed participants.

Healthy

Janssen Research & Development, LLC47 participantsStarted Mar 2014

Tempe, Arizona, United States

A Bioequivalence Study of the Fixed Dose Combination Tablets of Canagliflozin and Metformin Extended Release (XR) With Respect to the Individual Components

A Bioequivalence Study of the Fixed Dose Combination Tablets of Canagliflozin and Metformin Extended Release (XR) With Respect to the Individual Components in Healthy Fed Participants

Find Trials by Condition in Arizona

Safety and Efficacy of OMS302 in Subjects Undergoing Unilateral Cataract Extraction With Lens Replacement (CELR)

Long Term Follow-up Study With Keppra XR (Levetiracetam XR) for Partial Seizures

Conversion to Monotherapy Study With Keppra XR for Partial Seizures

Study Evaluating Rebif, Copaxone, and Tysabri for Active Multiple Sclerosis

Warfarin Versus Aspirin in Reduced Cardiac Ejection Fraction (WARCEF) Trial

Comparative Study of Three NNRTI-Sparing HAART Regimens

Valproic Acid in Treating Patients With Kaposi's Sarcoma

A Study of the Safety and Efficacy of Golimumab in Subjects With Rheumatoid Arthritis That Are Methotrexate-naive

A Study to Assess Treatment With 2 Different Dosing Schedules of Trabectidin Administered to Patients With Advanced Cancer

Clevidipine in the Treatment of Blood Pressure in Patients With Acute Heart Failure (PRONTO)

Early Feasibility Study 2 of Outpatient Control-to-Range - Testing System Efficacy

Clevidipine in the Treatment of Patients With Acute Hypertension and Intracerebral Hemorrhage (ACCELERATE)

Study of Adalimumab in Patients With Axial Spondyloarthritis

Study of an Oral Cdk Inhibitor Administered With an Oral BRAF Inhibitor in Patients With Advanced or Inoperable Malignant Melanoma With BRAF Mutation

Evaluation of the Effect of the InsuPatch Device on Insulin Pharmacokinetics in Clamp Studies

Evaluation of the Safety Use of the InsuPatch Device in Daily Life Conditions

Maraviroc Plus Darunavir/Ritonavir for Treatment-Naïve Patients Infected With R5-tropic HIV-1

Randomized Comparison Angioplasty Outcomes at Hospitals With and Without On-site Cardiac Surgery